Can recombinant human thrombomodulin increase survival among patients with severe septic-induced disseminated intravascular coagulation: a single-centre, open-label, randomised controlled trial

OBJECTIVE: To determine whether treatment with recombinant human thrombomodulin (rhTM) increases survival among patients with severe septic-induced disseminated intravascular coagulation (DIC). DESIGN: Single-centre, open-label, randomised controlled trial. SETTING: Single tertiary hospital. PARTICI...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:BMJ Open
Main Authors: Hagiwara, Akiyoshi, Tanaka, Noriko, Uemura, Tatsuki, Matsuda, Wataru, Kimura, Akio
Format: Artigo
Sprog:Inglês
Udgivet: BMJ Publishing Group 2016
Fag:
Intensive Care
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5223629/
https://ncbi.nlm.nih.gov/pubmed/28039291
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmjopen-2016-012850
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker